Norephedrine, deoxy-
Brand names,
Norephedrine, deoxy-
Analogs
Norephedrine, deoxy-
Brand Names Mixture
- Adderall (amphetamine + dextroamphetamine)
- Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
Norephedrine, deoxy-
Chemical_Formula
C9H13N
Norephedrine, deoxy-
RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
Norephedrine, deoxy-
fda sheet
Norephedrine, deoxy-
msds (material safety sheet)
Norephedrine, deoxy-
Synthesis Reference
U. S. Pat. 1,879,003, (1932)
Norephedrine, deoxy-
Molecular Weight
135.206 g/mol
Norephedrine, deoxy-
Melting Point
Volatizes slowly at room temperature
Norephedrine, deoxy-
H2O Solubility
Slightly
Norephedrine, deoxy-
State
Solid
Norephedrine, deoxy-
LogP
1.799
Norephedrine, deoxy-
Dosage Forms
Capsules
Norephedrine, deoxy-
Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
Norephedrine, deoxy-
Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
Norephedrine, deoxy-
Absorption
It forms easily absorbed molecules that are highly lipid soluble
Norephedrine, deoxy-
side effects and Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
Norephedrine, deoxy-
Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
Norephedrine, deoxy-
Organisms Affected
Humans and other mammals